RetinalGenix Technologies
RTGN · OTC
About RTGN
- Employees
- 0
- Headquarters
- Petaluma, California
- Listed
- Jan 7, 2022
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Website
- retinalgenix.com
RTGN key statistics
- Market cap
- 75.19M
- Price-earnings ratio
- —
- Dividend yield
- —
- Average volume
- 110
- Volume
- 3
- Open price
- $4.00
- High today
- $4.00
- Low today
- $3.99
- 52 Week high
- $4.01
- 52 Week low
- $3.20
RetinalGenix Technologies (RTGN) at a glance
RetinalGenix Technologies (RTGN) last traded at $3.99, with a market cap of 75.19M.
Today the stock has traded between $3.99 and $4.00. The current price is 0.0% above the day's low and 0.2% below its high.
Volume so far is 3 shares, below the average of 110 shares a day.
Over the past year RetinalGenix Technologies has ranged from $3.20 to $4.01, and now sits 98% of the way up that range.
Similar companies
Companies in the same industry as RetinalGenix Technologies
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.